American Oncology Network Azioni (OTC: AONC)

Ultime notizie per American Oncology Network (OTC:AONC) Azioni

American Oncology Network

American Oncology Network Inc is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. The company pioneers healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. It is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care needed to achieve optimal health outcomes.

AMER ONCOLOGY NETWORK A by American Oncology Network, Inc.

American Oncology Network Inc

American Oncology Network Inc Warrants (31/03/2028)

TD Cowen analyst Yaron Werber initiates coverage on Upstream Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPB#NASDAQ">UPB</a>) with a Buy rating.

News

Initiation

Analyst Ratings

TD Cowen Initiates Coverage On Upstream Bio with Buy Rating

Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Prime Video is unveiling an X-Ray Recaps feature to help users stay updated on their favorite shows, even after <a target="_blank" href="https://www.aboutamazon.com/news/entertainment/amazon-prime-video-x-ray-recaps" rel="noreferrer noopener">long breaks between episodes</a>.
Instead of rewinding or searching for plot summaries, viewers can now access spoiler-free, AI-generated recaps to refresh their memory quickly.
X-Ray Recaps uses generative AI to create concise summaries tailored to a user&#8217;s specific point in an episode or season.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41722824/apples-services-and-silicon-strategy-to-fuel-margins-justify-high-valuation-analyst" rel="noreferrer noopener">Apple&#8217;s Services And Silicon Strategy To Fuel Margins, Justify High Valuation: Analyst</a>
Whether viewers need a refresher on critical events halfway through a season or have missed crucial plot points, X-Ray Recaps provides clear, relevant context in short text segments.
This feature extends Prime Video&#8217;s existing X-Ray tool, which already offers cast, soundtrack, and trivia information to enhance the viewing experience.
Amazon&#8217;s new feature leverages Amazon Bedrock, an AWS service for creating and scaling AI applications.
The feature combines Bedrock&#8217;s AI and customized models trained on Amazon SageMaker to analyze video segments and subtitles to generate comprehensive yet spoiler-free summaries.
Guardrails ensure that the recaps avoid spoilers and keep the content concise, making it ideal for audiences eager to return to their shows without missing key developments.
Prime Video users can access X-Ray Recaps directly from the detail page or during playback within the X-Ray experience. Once activated, options include summaries for the current episode, the season, or the previous season.
The feature is currently in beta and is available to U.S. customers on Fire TV, with broader device support expected by the end of the year.
At launch, X-Ray Recaps will cover the Amazon MGM Studios Original series.
The move marks Amazon&#8217;s efforts to stay relevant versus streaming giants like Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>). Amazon Prime Video started offering lower ad prices than Netflix and other streaming rivals as it competes <a target="_blank" href="https://www.benzinga.com/news/24/07/40042764/amazon-challenges-netflix-with-cheaper-ad-slots-boosts-prime-video-ads-report" rel="noreferrer noopener">for advertiser interest</a>.
Bernstein analyst Mark Shmulik noted Amazon as a substantial investment, even with upcoming <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41737293/amazon-stock-buy-now-pay-off-later-says-analyst" rel="noreferrer noopener">infrastructure spending increases</a>. Shmulik sees Amazon&#8217;s core operations, AWS revenue, and Prime Video investments as key drivers, especially before the holiday season.
He emphasized that Amazon&#8217;s spending tends to yield solid returns, setting up for strong free cash flow in 2025.
<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41692259/amazon-analysts-see-growth-ahead-with-aws-in-early-innings-of-a-big-ai-cycle-advert" rel="noreferrer noopener">Analysts view Amazon Prime Video</a> as a strategic growth driver within Amazon&#8217;s expanding advertising segment. The recent introduction of Prime Video&#8217;s ad-supported tier will likely boost Amazon&#8217;s advertising revenue, with analysts like Truist&#8217;s Youssef Squali projecting significant contributions by fiscal 2025. BMO Capital&#8217;s Brian Pitz also noted that sports content and new AI-driven bidding tools could further enhance ad revenue potential.
Price Action: AMZN stock traded higher by 0.13% to $196.03 premarket at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41720954/disney-creates-new-tech-hub-for-ai-and-ar" target="_blank" rel="noreferrer noopener">Disney Creates New Tech Hub For AI and AR</a></li>
</ul>
Photo via Shutterstock

Tech

AMZN

NFLX

Amazon Takes on Netflix With New AI Recaps

TD Cowen analyst Joshua Jennings initiates coverage on CeriBell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBLL#NASDAQ">CBLL</a>) with a Buy rating and announces Price Target of $31.

Price Target

CBLL

TD Cowen Initiates Coverage On CeriBell with Buy Rating, Announces Price Target of $31

B of A Securities analyst Ross Fowler upgrades Idacorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDA#NYSE">IDA</a>) from Neutral to Buy and raises the price target from $113 to $117.

Upgrades

B of A Securities Upgrades Idacorp to Buy, Raises Price Target to $117

Contracts

RDWR

Radware Expands Customer Relationship With A Prominent US Based Communications Platform As A Service Provider In Multimillion-Dollar Deal

Emeren Enters Co-Development Agreement With Arpinge To Jointly Develop A 300 MW Battery Energy Storage System Portfolio In Southern Italy

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) remains vulnerable to Taiwan&#8217;s surging electricity prices, a shift that could impact the semiconductor industry.
Once a competitive edge, Taiwan&#8217;s low-cost energy has become more challenging to maintain, leading to increased costs for major industrial consumers, the Financial Times <a target="_blank" href="https://www.ft.com/content/cfd77e84-5d5b-47ae-96bd-9973b1c18662" rel="noreferrer noopener">reports</a>.
Taiwan Semiconductor now anticipates that electricity expenses in Taiwan will surpass those in its other significant locations, including the U.S., Japan, and Germany.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/10/41633790/apple-refreshes-macbook-pro-lineup-with-m4-pro-and-m4-max-3nm-chips" rel="noreferrer noopener">Apple Refreshes MacBook Pro Lineup With M4 Pro and M4 Max 3Nm Chips</a>
<a target="_blank" href="https://www.benzinga.com/markets/equities/24/11/41706702/nvidia-supplier-tsmc-to-double-advanced-chip-packaging-capacity-as-ai-demand-from-microsoft-amaz" rel="noreferrer noopener">Recent reports indicated</a> the chipmaker will double its advanced packaging capacity by 2025, largely to meet the rising demand for AI chips from major tech firms like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). The company&#8217;s CoWoS packaging technology is in high demand, with Nvidia expected to use more than half of the expanded capacity.
CFO Wendell Huang recently disclosed to investors that power costs in Taiwan have effectively doubled over the past few years and will likely be Taiwan Semiconductor&#8217;s highest globally by 2024.
Taiwan&#8217;s government has raised electricity prices four times since 2022, with increases primarily affecting industrial users like Taiwan Semiconductor.
In line with its broader energy transition, Taiwan aims to boost renewable energy to supply up to 30% of its power by 2030. However, a recent emphasis on scaling back coal and nuclear power has made it increasingly challenging to meet industrial demands.
According to FT, Taiwan relies on coal and liquefied natural gas for over 80% of its energy supply, with renewable sources accounting for only 9.5%.
The rising electricity rates alone may not significantly hinder Taiwan Semiconductor&#8217;s operations, as power costs constitute a minor portion of its overall expenses. However, consistent supply disruptions could threaten Taiwan Semiconductor&#8217;s ability to expand its production capacity in Taiwan, FT writes.
Taiwan Semiconductor stock has gained 89% year-to-date. Investors can gain exposure to the stock through the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) and the First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDIV#NASDAQ">TDIV</a>).
Price Actions:&nbsp;TSM stock traded higher by 1.17% to $193.80 premarket at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/11/41726213/applied-materials-and-lam-research-shift-supply-chains-away-from-china-to-meet-new-us-guidelines" target="_blank" rel="noreferrer noopener">Applied Materials and Lam Research Shift Supply Chains Away from China to Meet New US Guidelines</a></li>
</ul>
Photo by wakamatsu.h via Shutterstock

Government

Regulations

Media

MSFT

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TDIV

Taiwan Semiconductor Faces Rising Energy Costs, Potential Outages Threaten Production

As the United States approaches the election, Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) has seen a notable 5.15% increase in pre-market trading on Tuesday, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>. This surge comes as traders perceive the company&#8217;s stock as a potential indicator of Donald Trump&#8217;s reelection chances.
What Happened: The recent uptick in Trump Media &amp; Technology Group&#8217;s stock is linked to the upcoming U.S. elections. On Monday, DJT closed 12.37% higher at $34.34.
Traders are treating Trump&#8217;s stock as a gauge for his reelection prospects. If Trump wins, his platform, Truth Social, is expected to play a significant role in his communication strategy, akin to his use of X during his presidency, according to <a href="https://www.cnbctv18.com/world/share-of-donald-trumps-social-media-firm-surge-on-eve-of-the-us-election-day-19503834.htm">CNBC</a>. However, if Vice President Kamala Harris wins, the future of Truth Social could face challenges.
See Also: <a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retaking The White House With &#8216;Large Majority Of Swing States&#8217;</a>
This development is occurring as the nation gears up for a pivotal election, with market participants closely watching political dynamics. The performance of Trump Media &amp; Technology Group&#8217;s stock reflects broader sentiments regarding the election&#8217;s potential outcomes and their implications for Trump&#8217;s media ventures.
Why It Matters: The election race between Trump and Harris has tightened, with recent polls showing <a href="https://www.benzinga.com/general/politics/24/11/41733277/harris-vs-trump-vice-president-has-two-point-lead-in-final-election-poll-swing-states-remain-clo">Harris maintaining a slight lead</a> over Trump. However, her lead has been shrinking, indicating a closely contested election. This uncertainty adds to the volatility surrounding Trump Media &amp; Technology Group&#8217;s stock.
Additionally, options activity for <a href="https://www.benzinga.com/insights/options/24/11/41717863/this-is-what-whales-are-betting-on-trump-media-technology">Trump Media &amp; Technology</a> has seen significant movement, with deep-pocketed investors showing a divided sentiment. While 36% of these investors are bullish, 48% are bearish, indicating mixed expectations about the company&#8217;s future. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/11/41722178/if-trump-and-republicans-sweep-dollar-may-climb-7-but-harris-win-could-bring-5-drop-says-jpmorgan?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If Trump And Republicans Sweep, Dollar May Climb 7% — But Harris Win Could Bring 5% Drop, Says JPMorgan</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Equities

Pre-Market Outlook

Markets

General

Trump Media (DJT) Stock Rises Over 6% In Pre-Market Ahead Of Presidential Election Eve

Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) sees Q4 sales of $70.000 million-78.000 million vs $79.10 million estimate.

Guidance

Vishay Precision Group Sees Q4 Sales $70.000M-78.000M vs $79.10M Est

TD Cowen analyst Bill Katz downgrades Affiliated Managers Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMG#NYSE">AMG</a>) from Buy to Hold and lowers the price target from $226 to $177.

Downgrades

TD Cowen Downgrades Affiliated Managers Group to Hold, Lowers Price Target to $177

Vishay Precision Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VPG#NYSE">VPG</a>) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.26 by 26.92 percent. This is a 59.57 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $75.73 million which missed the analyst consensus estimate of $76.71 million by 1.28 percent. This is a 11.80 percent decrease over sales of $85.85 million the same period last year.

Earnings

Earnings Misses

Vishay Precision Group Q3 Adj $0.19 Misses $0.26 Estimate, Sales $75.73M Miss $76.71M Estimate

CRVL

CorVel Q2 EPS $1.35 Up From $1.15 YoY, Sales $224M Up From $196M YoY

Deutsche Bank analyst Bryan Keane downgrades Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) from Buy to Hold and lowers the price target from $9 to $4.

Deutsche Bank Downgrades Marqeta to Hold, Lowers Price Target to $4

BTIG analyst Sean Lavin downgrades Tactile Systems Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) from Buy to Neutral.

TCMD

BTIG Downgrades Tactile Systems Tech to Neutral

INGR

Ingredion Now Expects FY24 Net Sales To Be Down Mid-Single-Digits (Prior View: Down Low Single-Digits), Excluding Effects Of Sale Of South Korea Business

Ingredion Raises FY24 Adjusted EPS Outlook From $9.70 - $10.20 To $10.35 - $10.65, Est $9.97

2024 Financial Guidance
The Company is updating certain metrics for its full-year 2024 guidance, as detailed in the table below:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Financial Metric</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Prior FY 2024 Guidance</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Updated FY 2024 Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenues</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$935 million to $955 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$930 million to $940 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$580 million to $595 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$580 million to $590 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest expense</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$320 million to $330 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cash flow from operations</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$135 million to $150 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$135 million to $145 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital expenditures</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$120 million to $130 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Depreciation</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$80 million to $90 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Amortization of intangible assets</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$345 million to $350 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Effective tax rate</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">25% to 28%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(unchanged)</td>
</tr>
</tbody>
</table>
</figure>

Health Care

MPLN

MultiPlan Expects 2024 Revenues Of $930M-$940M Compared With Prior Guidance $935M-$955M And Consensus Of $939.207M

Patria Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAX#NASDAQ">PAX</a>) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.24 by 4.17 percent. This is unchanged from the same period last year. The company reported quarterly sales of $77.700 million which beat the analyst consensus estimate of $76.058 million by 2.16 percent. This is a 25.93 percent increase over sales of $61.700 million the same period last year.

Earnings Beats

Patria Investments Q3 2024 Adj. EPS $0.23 Misses $0.24 Estimate, Sales $77.700M Beat $76.058M Estimate

Bernstein analyst Nikhil Devnani upgrades eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) from Market Perform to Outperform and announces $70 price target.

EBAY

Bernstein Upgrades eBay to Outperform, Announces $70 Price Target

2024 Financial Guidance
<ul>
<li>2024 total sales growth is now expected to be 4% to 5% over 2023, compared with prior guidance of 4% to 6% growth.</li>
<li>2024 non-GAAP diluted EPS attributable to Henry Schein, Inc. is now expected to be $4.74 to $4.82, compared with prior guidance of $4.70 to $4.82, and reflects growth of 5% to 7% compared with 2023 non-GAAP diluted EPS of $4.50.</li>
<li>2024 Adjusted EBITDA is expected to grow in the low-double-digit percentages versus 2023 Adjusted EBITDA, and is unchanged compared to prior guidance.</li>
</ul>

HSIC

Henry Schein Expects 2024 Adjusted EPS Of $4.74 To $4.82 Compared With Prior Guidance Of $4.70-$4.82 And Consensus Of $4.75

An update from American Oncology Network (AONC) is now available. David H. Gould has announced his resignation as the principal financial officer a...

American Oncology Network Announces Key Officer Changes

American Oncology Network GAAP EPS of -$1.22, revenue of $364.34M

American Oncology Network, Inc. (AONC) Q1 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
American Oncology Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/aonc-stock-quote/">AONC</a>) just reported results for the first quarter of 2024.<ul><li>American Oncology Network reported earnings per share of -$1.22.</li><li>The company reported revenue of $364.34 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/aonc-stock-earnings-american-oncology-network-for-q1-of-2024/">AONC Stock Earnings: American Oncology Network Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AONC Stock Earnings: American Oncology Network Reported Results for Q1 2024

American Oncology Network to delist its class A stock, warrants from Nasdaq

Tandem Diabetes Care, Guardion Health, GT Biopharma among healthcare movers

American Oncology Network appoints David Afshar as chief financial and operating officer

The latest update is out from American Oncology Network (AONC). The American Oncology Network, Inc. has appointed David Afshar as its new Chief Fin...

American Oncology Network Welcomes New CFO and COO

American Oncology Network GAAP EPS of -$0.11, revenue of $433.98M

Community oncology practice Florida Oncology and Hematology, a partner practice of American Oncology Network (AONC), is announces patients now have...

American Oncology Network partner opens new location in Cape Coral

AONC

AONCW

BDRX

GHSI

GTBP

LSDI

MYMD

SABS

TNDM

XYLO

Press Releases

American Oncology Network Announces Voluntary Delisting From Nasdaq

Management

American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer

American Oncology Network Announces the Research Studies Presented at the ASCO 2024 Annual Meeting

American Oncology Network Expands Radiation Oncology Services, Opens New Clinic

OTC Markets Group Welcomes American Oncology Network, Inc. to OTCQX

American Oncology Network Announces the Commencement of OTCQX Trading

Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium

American Oncology Network Announces Second Quarter 2024 Earnings Release Date and Conference Call

Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann

Comments

American Oncology Network

Notizie

Ultime notizie per American Oncology Network (OTC:AONC) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO